Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.985
+0.097 (10.96%)
Nov 21, 2024, 2:24 PM EST - Market open
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 100 employees as of December 31, 2023. The number of employees increased by 78 or 354.55% compared to the previous year.
Employees
100
Change (1Y)
78
Growth (1Y)
354.55%
Revenue / Employee
$92,100
Profits / Employee
-$849,910
Market Cap
44.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accelerate Diagnostics | 134 |
BioLineRx | 79 |
iCAD, Inc. | 69 |
AN2 Therapeutics | 41 |
LAVA Therapeutics | 37 |
Nexalin Technology | 6 |
Lexaria Bioscience | 5 |
VRCA News
- 6 hours ago - Verrica Announces Pricing of $42.0 Million Public Offering - GlobeNewsWire
- 22 hours ago - Verrica Announces Proposed Public Offering - GlobeNewsWire
- 22 days ago - Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements - PRNewsWire
- 4 weeks ago - Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference - GlobeNewsWire
- 5 weeks ago - VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA - Business Wire
- 7 weeks ago - Verrica Pharmaceuticals Announces Restructuring of Commercial Organization - GlobeNewsWire
- 7 weeks ago - VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA - PRNewsWire
- 2 months ago - Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York - GlobeNewsWire